Hovione recently published results of a phase 2b study showed a topcial gel formulation of 1% and 3% minocycline proved to be an effective and safe treatment for papulopustular rosacea.
An analysis by Vanguard Communications suggests more weight is attached to physician patient reviews compared to those of hotels and restaurants.
South Florida practitioner Dr. Susan Weinkle received the JDD Outstanding Educator & Mentor in Dermatology at the ODAC held Jan.17-20 in Orlando, Fla. The award recognizes continuing contributions to the dermatology industry through education.
With advancements in deep next-generation sequencing (NGS) and bioinformatics analysis, the authors of a recent study suggest the skin microbiome may hold promise as a clinical biomarker in atopic dermatitis (AD) management.
A recent study reports findings that support dupilumab as a safe, long-term treatment in patients with moderate-to-severe atopic dermatitis.
Pediatric patients with psoriasis who experience a significant improvement in disease severity after treatment may experience the greatest positive impact to quality of life, according to a recent study.
A new systemic medication option offers promising results for patients with high-risk squamous cell carcinoma for whom surgery has not worked, says this expert.
Crown Laboratories has announced business division restructuring to establish themselves in the global skin care and dermatology market.
Verrica released positive data from its post-hoc pooled analysis of pivotal phase 3 trials investigating the safety and efficacy of VP-102 for the treatment of molluscum contagiosum.
An expert weighs in on the factors driving a growing number of dermatologists to sell their practices.